Zur Zeit liegt uns keine Inhaltsangabe vor.
Inhaltsverzeichnis
I. Introduction. - 1. B Cell/Leukemia Panel Workshop: Summary and Comments. - II. Serologic Specificity of B Cell/Leukemia Monoclonal Antibodies. - 2. Analysis of the B Cell/Leukemia Workshop Monoclonal Antibodies Using an Immunoenzymatic Staining Assay and a Radioimmunoassay on Cells. - 3. Analysis of Ten B Lymphocyte-Specific Workshop Monoclonal Antibodies. - 4. Screening of Workshop B Series Antibodies by Radioimmunobinding to Human Leukocyte Cell Lines and to Cells from Human Lymphoid Tumors. - 5. Expression of Lymphocyte Differentiation Antigens in Immunodeficiency Diseases. - 6. Use of Two Monoclonal Anti-Human B Cell Antibodies in the Study of Early B Cell Differentiation. - 7. Characterization of a Human B Lymphocyte-Specific Antigen Defined by Monoclonal Antibodies HD6 and HD39. - 8. Six Distinct Antigen Systems of Human B Cells as Defined by Monoclonal Antibodies. - 9. B-C1, B-C2, B-C3: Monoclonal Antibodies against B Cell Differentiation Antigens. - 10. Human B Cells: Is FMC7 a Marker for Relatively Mature B Cells or Does It Define a Population Equivalent to the LyB5-Negative Mouse B Cells? . - 11. Spontaneous Mouse Erythrocyte Rosette Formation (M-RFC) with Human B Lymphocytes: Diagnostic Value in B-Lymphoproliferative Diseases and Lack of Relationship to B Cell Protocol Monoclonal Antibodies. - III. Biochemical Analysis of Antigens Defined by the Workshop B Cell/Leukemia Panel. - 12. Human B Cell Surface Molecules Defined by an International Workshop Panel of Monoclonal Antibodies. - 13. Structural Analysis of Cell Surface Molecules Recognized by Leukemic Cell/B Cell Panel Antibodies. - 14. Biochemical Analysis of Antigens Recognized by Workshop B Series Antibodies, Using Western Blotting . - 15. Human B Cell Antigens Detected by the Workshop Antibodies: AComparison of Serological and Immunochemical Patterns. - 16. Further Evidence that the Human Differentiation Antigen p24 Possesses Activity Associated with Protein Kinase. - 17. Clustering of Anti-Leukemia and Anti-B Cell Monoclonal Antibodies. - 18. A Structurally Novel Human B Cell Surface Molecule. - 19. Human Neutrophils Synthesize Different Forms of the Common Acute Lymphoblastic Leukemia Antigen. - IV. Immunohistochemical Analysis of B Cell/Leukemia Panel Monoclonal Antibodies. - 20. Immunohistochemical Analysis of Monoclonal Anti-B Cell Antibodies. - 21. Analysis of B and L Workshop Antibodies on Sections of Normal and Neoplastic Lymphoid Tissue and Cell Lines. - 22. Immunohistological Analysis of Tissue Specificity of the Fifty-two Workshop Anti-B Lymphocyte Monoclonal Antibodies. - 23. Reactivity of Monoclonal Antibodies of the B and L Series with Follicular Dendritic Cells in Tissue Sections and with Lymphoblastoid Cell Lines. - 24. The Staining of a Panel of Routine Diagnostic Tissue Biopsies with the Workshop L Series Antibodies. - 25. Immunohistochemical Reactivity of Anti-B Cell Monoclonal Antibodies in Thymus, Lymph Node, and Normal Skin. - 26. Report to Second International Workshop on Human Leukocyte Differentiation Markers: Boston, 1984. Tissue Localization of B Cell and Leukemic Reagents (Special Studies). - V. Expression of B Cell/Leukemia Panel on Leukemias and Lymphomas. - 27. Quantitative Phenotypes of B Chronic Lymphocytic Leukemia B Cells Established with Monoclonal Antibodies from the B Cell Protocol. - 28. Analysis of Workshop L Series Antibodies: Radioimmunobinding and Biochemical Studies. - 29. Subclassification of Leukemia Using Monoclonal Antibodies. - 30. Immunological Classification of Unclassifiable Acute Leukemia. - 31. AgePredilection of Distinct Phenotypically Defined Subgroups of Non-T Cell ALL: Studies Using B Cell-Restricted or -Associated Monoclonal Antibodies in 359 Patients. - 32. Heterogeneity of B-CLL Cells Defined by Monoclonal Antibodies. - 33. HD37 Monoclonal Antibody: A Useful Reagent for Further Characterization of Non-T, Non-B Lymphoid Malignancies. - 34. Characterization of Burkitt s Lymphoma Cell Lines with Monoclonal Antibodies Using an ELISA Technique. - VI. Functional Significance of Human B Cell/Leukemia Antigens. - 35. Human B Cell Populations Defined by the B1 and B2 Antigens. - 36. Phenotypic Changes Occurring during in vitro Activation of Human Splenic B Lymphocytes. - 37. Antigenic Changes of the B Cell Panel of the Second International Workshop on Human Leukocyte Differentiation Antigens with in vitro Activation. - 38. Activation of Human B Cells with Monoclonal Antibody to the Bp32 Cell Surface Polypeptide. - 39. B Lymphocyte Surface Antigens Involved in the Regulation of Immunoglobulin Secretion. - 40. Inhibition of Immunoglobulin Secretion, But Not Immunoglobulin Synthesis, by a Monoclonal Antibody. - 41. Monoclonal Antibody AB1 Identifies a Human B Cell Activation Antigen and Inhibits Growth Factor-Dependent Human B Cell Proliferation. - 42. Detection and Functional Studies of IL-2 Receptors on Activated Human B Cells. - 43. The C3d Receptor Identified by the HB-5 Monoclonal Antibody: Expression and Role as a Receptor for Epstein-Barr Virus. - 44. The B Cell-Restricted Glycoprotein (B2) Is the Receptor for Epstein-Barr Virus. - 45. Monoclonal Antibody-Defined Cell Surface Molecules Regulate Lymphocyte Activation. - 46. TPA-Induced Modulation of B Cell Differentiation Antigens Defined by Monoclonal Antibodies (HD6, HD28, HD37, HD39). - 47. Functional Studies of p24:Platelet Aggregation Inhibition by Fab Monomers of BA-2.